πŸ‡ΊπŸ‡Έ FDA
Patent

US 11576883

L-DOPA microbiome therapy

granted A61KA61K2035/115A61K31/198

Quick answer

US patent 11576883 (L-DOPA microbiome therapy) held by The Board of Regents of the University of Texas System expires Mon Feb 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Feb 14 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
29
CPC classes
A61K, A61K2035/115, A61K31/198, A61K35/741, A61K9/0053